Medicamen Biotech Limited

BSE:531146 Stok Raporu

Piyasa değeri: ₹7.0b

Medicamen Biotech Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 1/6

Medicamen Biotech's earnings have been declining at an average annual rate of -0.4%, while the Pharmaceuticals industry saw earnings growing at 13.4% annually. Revenues have been growing at an average rate of 7.8% per year. Medicamen Biotech's return on equity is 3.2%, and it has net margins of 4.5%.

Anahtar bilgiler

-0.4%

Kazanç büyüme oranı

-3.0%

EPS büyüme oranı

Pharmaceuticals Sektör Büyümesi17.5%
Gelir büyüme oranı7.8%
Özkaynak getirisi3.2%
Net Marj4.5%
Son Kazanç Güncellemesi30 Jun 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Gelir ve Gider Dağılımı

Medicamen Biotech nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

BSE:531146 Gelir, gider ve kazançlar (INR Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 241,804813130
31 Mar 241,7931093350
31 Dec 231,7071272860
30 Sep 231,5971332620
30 Jun 231,4971542270
31 Mar 231,4091482180
31 Dec 221,2501371980
30 Sep 221,2201371780
30 Jun 221,2101431590
31 Mar 221,1541491560
31 Dec 211,1391581360
30 Sep 211,1421501230
30 Jun 211,125140970
31 Mar 211,127121960
31 Dec 201,150110970
30 Sep 201,1741161000
30 Jun 201,222123970
31 Mar 201,2551331010
31 Dec 191,353136900
30 Sep 191,241124850
30 Jun 191,210123790
31 Mar 191,227120860
31 Dec 181,187110940
30 Sep 181,229117970
30 Jun 181,183108910
31 Mar 181,115101990
31 Dec 171,045941000
30 Sep 1796281950
30 Jun 1791265750
31 Mar 1782552710
31 Dec 1678258550
30 Sep 1672326520
30 Jun 1667318540
31 Mar 166735610
31 Dec 15679-131370
30 Sep 15667-21370
30 Jun 15760-1650
31 Mar 157794680
31 Dec 1481601290
30 Sep 14807-11260
30 Jun 14738-1570
31 Mar 1473211230
31 Dec 13696-71250

Kaliteli Kazançlar: 531146 has high quality earnings.

Büyüyen Kar Marjı: 531146's current net profit margins (4.5%) are lower than last year (10.3%).

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 531146's earnings have declined by 0.4% per year over the past 5 years.

Büyüme Hızlandırma: 531146's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Kazançlar vs. Sektör: 531146 had negative earnings growth (-47.5%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (19.1%).

Özkaynak Getirisi

Yüksek ROE: 531146's Return on Equity (3.2%) is considered low.

Varlık Getirisi

Kullanılan Sermaye Getirisi

Geçmişte güçlü performans gösteren şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y